Pfizer Total Liabilities 2010-2024 | PFE

Pfizer total liabilities for the quarter ending September 30, 2024 were $126.918B, a 7.72% increase year-over-year.

  • Pfizer total liabilities for 2023 were $137.213B, a 35.47% increase from 2022.
  • Pfizer total liabilities for 2022 were $101.288B, a 2.62% decline from 2021.
  • Pfizer total liabilities for 2021 were $104.013B, a 14.61% increase from 2020.

Pfizer Total Liabilities 2010-2024 | PFE

  • Pfizer total liabilities for 2023 were $137.213B, a 35.47% increase from 2022.
  • Pfizer total liabilities for 2022 were $101.288B, a 2.62% decline from 2021.
  • Pfizer total liabilities for 2021 were $104.013B, a 14.61% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B